Literature DB >> 14965255

Placental drug transporters.

Jashvant D Unadkat1, Amber Dahlin, Shashi Vijay.   

Abstract

Any treatment of a pregnant woman with medication (drugs) de facto results in the treatment of her unborn child, even when her unborn child is not the target of drug therapy. This is because, in most instances, the placenta is not a complete barrier to the passage of drugs from the maternal to the fetal compartment. This barrier is in part due to the presence of various efflux transporters in the placenta. The placenta is also richly endowed with influx transporters. In this article, we will review the physiological characteristics of the placenta and how it functions as a barrier to passage of drugs into the fetal compartment. In addition, we will review placental transporters that are important in modulating the exposure of the fetus to drugs and, therefore, the efficacy and toxicity of such drugs towards the fetus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14965255     DOI: 10.2174/1389200043489171

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  20 in total

1.  Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses.

Authors:  Zufei Zhang; Marjorie Z Imperial; Gabriela I Patilea-Vrana; Janak Wedagedera; Lu Gaohua; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2017-06-06       Impact factor: 3.922

2.  Placental transport of brevetoxin-3 in CD-1 mice.

Authors:  Janet M Benson; Andrea P Gomez; Gloria L Statom; Brad M Tibbetts; Lora E Fleming; Lorraine C Backer; Andrew Reich; Daniel G Baden
Journal:  Toxicon       Date:  2006-08-18       Impact factor: 3.033

Review 3.  Biological barriers, and the influence of protein binding on the passage of drugs across them.

Authors:  Karolina Wanat
Journal:  Mol Biol Rep       Date:  2020-03-05       Impact factor: 2.316

4.  Clomipramine concentration and withdrawal symptoms in 10 neonates.

Authors:  Peter G J ter Horst; Susanne van der Linde; Jan Pieter Smit; Jan den Boon; Richard A van Lingen; Frank G A Jansman; Lolkje T W De Jong-van den Berg; Bob Wilffert
Journal:  Br J Clin Pharmacol       Date:  2012-02       Impact factor: 4.335

Review 5.  ATP-binding cassette efflux transporters in human placenta.

Authors:  Zhanglin Ni; Qingcheng Mao
Journal:  Curr Pharm Biotechnol       Date:  2011-04       Impact factor: 2.837

Review 6.  Drug transporters in the human blood-placental barrier.

Authors:  Kirsi Vähäkangas; Päivi Myllynen
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

7.  Effects of Antiviral Drugs on Organic Anion Transport in Human Placental BeWo Cells.

Authors:  Tomohiro Nabekura; Tatsuya Kawasaki; Yuki Kamiya; Yuichi Uwai
Journal:  Antimicrob Agents Chemother       Date:  2015-09-28       Impact factor: 5.191

8.  Prescription drugs among pregnant women in Lome, Togo, West Africa.

Authors:  Yao Potchoo; Datouda Redah; Malick A Gneni; Innocent P Guissou
Journal:  Eur J Clin Pharmacol       Date:  2009-04-01       Impact factor: 2.953

9.  Medication use during pregnancy and the risk of childhood cancer in the offspring.

Authors:  Joachim Schüz; Thomas Weihkopf; Peter Kaatsch
Journal:  Eur J Pediatr       Date:  2007-03-08       Impact factor: 3.183

10.  Profiling gene expression in human placentae of different gestational ages: an OPRU Network and UW SCOR Study.

Authors:  Andrei M Mikheev; Tomohiro Nabekura; Amal Kaddoumi; Theo K Bammler; Rajgopal Govindarajan; Mary F Hebert; Jashvant D Unadkat
Journal:  Reprod Sci       Date:  2008-11       Impact factor: 2.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.